Korean J Psychopharmacol.  2006 Jan;17(1):91-94.

Lamotrigine as an Augmentation Agent in Treatment-Resistant Bipolar Depression: A Case Report

Affiliations
  • 1Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea. wmbahk@catholic.ac.kr

Abstract

The anticonvulsant lamotrigine has been reported to be efficacious and well tolerated in treatment of bipolar patients. Moreover, there were several reports that lamotrigine was effective for patients with treatment-resistant bipolar depression. Nevertheless, there was no report regarding the efficacy of lamotrigine as an augmentation agent in treatment-resistant bipolar depression in Korea. Here we present one case of a female patient suffering from treatment-resistant bipolar depression in which lamotrigine was successfully used as an augmentation treatment.

Keyword

Lamotrigine; Treatment-resistant; Bipolar depression
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr